RRC ID 39313
著者 Mogi M, Kinpara K, Kondo A, Togari A.
タイトル Involvement of nitric oxide and biopterin in proinflammatory cytokine-induced apoptotic cell death in mouse osteoblastic cell line MC3T3-E1.
ジャーナル Biochem Pharmacol
Abstract We previously demonstrated that the addition of proinflammatory cytokines (tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma) caused induction of mRNAs for inducible nitric oxide (NO) synthase and GTP cyclohydrolase I, a rate-limiting enzyme for 5,6,7,8-tetrahydrobiopterin (BH4) biosynthesis, and produced their end-products, NO and BH4, in osteoblastic cells. In the present study, we examined whether NO and BH4, biologically active substances produced in response to proinflammatory cytokines, are involved in the effect of these cytokines on cell viability and apoptotic cell death involving DNA fragmentation. Cytokines as well as S-nitroso-N-acetyl-d,l-penicillamine, an NO generator, decreased cell viability, whereas sepiapterin, which was converted intracellularly to BH4, increased it. The examination of cytotoxicity measured in terms of lactate dehydrogenase release and apoptotic cell death assessed by flow cytometric analysis showed that cytokine-induced reduction of cell viability may be based upon cell death by apoptosis, but not lytic death as in necrosis. In the presence of sepiapterin, cytokine treatment resulted in a statistically pronounced reduction in the amount of DNA fragmentation. Furthermore, this fragmentation could be blocked by 2-(4-carboxy-phenyl)-4,4,5,5-tetramethylimidazole-1-oxyl 3-oxide, an NO scavenger. These results suggest that cytokine-induced apoptotic cell death is attributed to NO and is protected by BH4, and that osteoblastic cells in response to proinflammatory cytokines operate both a stimulatory process resulting in NO production and an inhibitory one resulting in BH4 production for apoptotic cell death. Cytokine-induced apoptotic cell death may be a consequence of the predominance of the stimulatory process over the inhibitory process.
巻・号 58(4)
ページ 649-54
公開日 1999-8-15
DOI 10.1016/s0006-2952(99)00131-8
PII S0006-2952(99)00131-8
PMID 10413302
MeSH 3T3 Cells Animals Antioxidants / pharmacology* Apoptosis* Biopterin / analogs & derivatives* Biopterin / pharmacology Cytokines / physiology* Inflammation Mediators / physiology* Interferon-gamma / physiology Interleukin-1 / physiology Mice Nitric Oxide / physiology* Osteoblastoma Osteoblasts / drug effects Osteoblasts / physiology* Tumor Cells, Cultured Tumor Necrosis Factor-alpha / physiology
IF 4.96
引用数 40
WOS 分野 PHARMACOLOGY & PHARMACY
リソース情報
ヒト・動物細胞 MC3T3-E1(RCB1126)